All Episodes
VJOncology Podcast — 233 episodes
New frontiers in brain tumor treatment: from immunotherapy to precision medicine
Gynecologic cancer awareness month: recent advances in treatment and diagnosis
Beyond lutetium: the next wave of radiopharmaceuticals in prostate cancer
Immunotherapy updates in head and neck cancer from ASCO 2026
Updates in skin cancer from ASCO 2026
iwCAR-T 2026: advances in TIL therapy for solid tumors
Beyond the algorithm: trust, evidence and equity in AI-enabled cancer care
GU cancer highlights from ASCO 2026
Top updates from the ESMO Gastrointestinal Cancers Congress 2026
Highlights in lung cancer from ASCO 2026: LIBRETTO-432, CROWN, and more
Breast cancer highlights from ASCO 2026
Gastrointestinal cancer updates at ASCO 2026: RASolute 302, EMERALD-3, and more
Highlights from ASCO 2026
iwCAR-T 2026: CARs targeting cell surface proteins
Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs
Oncology highlights from AACR 2026
Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
Head and neck cancer awareness month: key trials and evolving treatment strategies
Lung cancer highlights from the 24th BTOG annual conference
Immuno-oncology updates from 12th Immunotherapy of Cancer Conference
Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer
Esophageal cancer awareness month: from multidisciplinary dialogue to clinical impact
ctDNA-guided surveillance and treatment monitoring in breast cancer
What’s new in checkpoint inhibition? LAG-3/PD-1 bispecifics, ADC combos, and more
Cervical cancer awareness month: advances in prevention and treatment
Immunotherapy's expanding role in GI cancers: from 1L to adjuvant settings
From biology to breakthroughs: new frontiers in head and neck cancer immunotherapy
How is AI transforming oncology care in 2026? From evidence to clinical practice
Highlights from SABCS 2025
Updates in GU cancer at ESMO 2025: SunRISe-4, PSMAddition, and more
GI cancer highlights at ESMO 2025: FORTITUDE-101, STELLAR-303, and more
Lung cancer at ESMO 2025: new targets, biomarkers & the changing landscape
ESSO 44: the latest updates in surgical oncology
Breast Cancer Awareness Month - the evolving role of ADCs
Highlights from ESMO 2025
Liver cancer awareness month: evolving strategies in immunotherapy and targeted treatment
Challenges and opportunities in cerebrospinal fluid liquid biopsies in brain tumors
From cold tumors to hot targets: immunotherapy advances in sarcoma treatment
WCLC 2025 highlights: FLAURA2, HARMONi, and more
Precision medicine in head & neck cancer: the rise of ADCs and targeted agents
Therapeutic options beyond ADCs in HER+ breast cancer
AI in Oncology: From Detection to Treatment
GI cancer highlights from ASCO 2025 with J. Randolph Hecht, Jasmine Mitchell and Jingran Ji
Highlights in GU cancer at ASCO 2025
Evolving strategies in gynecologic cancer care
Sarcoma awareness month: advances in precision medicine
CAR-T and cellular therapy updates in brain tumors
Breakthrough advances from ESMO GI 2025
Lung cancer highlights from ASCO 2025 with Joao Victor Alessi and Alessandro Di Federico
Breast Cancer highlights from ASCO 2025 with Kevin Kalinsky and Komal Jhaveri
Gynecological cancer updates at ASCO 2025
Breakthrough advances from ASCO 2025
Expanding Cell Therapy - TILs, TCRs & CARs in Lung Cancer and Melanoma
VJOncoAlert Journal Club
Adjuvant Therapy for Hepatocellular Carcinoma
Prostate cancer awareness month: advances in liquid biopsies
BTOG 2025 highlights
Liquid biopsy in breast cancer
Prostate cancer awareness month: developments in radioligand therapy
Key updates at ASCO GU 2025: STAMPEDE, CheckMate 214, and more
Cellular therapies in solid tumors
Therapeutic options for PD1 refractory skin cancer
Unlocking the Potential of ctDNA in Colorectal Cancer Management
Breast Cancer Updates from SABCS 2024
Novel immune checkpoint targets beyond PD-1 and CTLA-4 in solid tumors
Antibody drug conjugates in gastrointestinal cancers
Novel therapeutics in PD-1 refractory melanoma
Climate Change and Other Environmental Factors on Lung Cancer Risk at WCLC 2024
GI updates from ESMO 2024
Updates in the management of refractory colorectal cancer
ESSO 43 Highlights
Highlights from ESMO 2024
Latest updates in managing brain metastases
Updates in immunotherapy for GU cancer
Advancements in precision medicine for colorectal cancer
iwCAR-T sessions: clinical advances in GI cancers
iwCAR-T sessions: cell therapies for melanoma and sarcomas
iwCAR-T sessions: Advances in breast and gynecological cancers
iwCAR-T sessions: CAR-T clinical advances in lung cancer
Highlights in colorectal cancer at ASCO and ESMO GI 2024
Skin Cancer Highlights at ASCO 2024
iwCAR-T sessions: Clinical Advances in Head and Neck Cancer and Brain Tumors
ELCC 2024 highlights
Key Updates from ESMO Breast 2024
Bladder Cancer Awareness Month Part II: Management of UC in the UK
Bladder Cancer Awareness Month Part I: The past, present, and future of ADCs
BTOG 2024 Highlights
Highlights from AACR 2024: KRYSTAL-1, FLAURA2, and EDGE
Updates in immunotherapy for head and neck cancer
Updates in immunotherapy for skin cancer
Highlights in colorectal cancer at ASCO GI 2024
Targeted therapies for lung cancer at TTLC 2024
Updates in invasive lobular carcinoma (ILC)
Esophageal and gastric cancer highlights from ASCO GI 2024
Key updates at ASCO GU 2024
Highlights in bladder and prostate cancer at PROCSA/BLADDR 2023
Key updates at ESMO Asia 2023
Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino
Updates in GI cancer at ESMO 2023
2023 updates in metastatic colorectal cancer genomic biomarkers
Highlights in cancer nursing at UKONS 2023
Highlights in gynecologic cancer from ESMO 2023
Highlights in breast cancer from ESMO 2023
Highlights in lung cancer from ESMO 2023
Highlights in GU cancer at ESMO 2023
EGFR exon 20 insertions and how to manage patients in the UK
Updates in immunotherapy for brain tumors
Developments in radiotherapy for GI cancer
Latest advances in early-stage breast cancer
Applications of AI in Oncology
Targeted radionuclide therapy in prostate cancer
Latest updates in mesothelioma
iwCAR-T Session V: Advances in head & neck and CNS cancers
Highlights in GI cancer from ESMO WCGIC 2023
Updates in immunotherapy for head and neck cancer
iwCAR-T session VI: Advances in GI cancers
Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR
ASCO 2023 Highlights: THOR, INDIGO and ADAURA
iwCAR-T Session III: CAR-T clinical advances in lung cancer
iwCAR-T Session II: Cell therapies in GU cancers
iwCAR-T Session I: Emerging CARs and future challenges in solid tumors
Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors
Liquid biopsy in lung cancer: precision medicine and MRD
St. Gallen highlights: controversies in the axilla
Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala
Chemotherapy, post-adjuvant therapy, and clinical trial ethics at St Gallen BCC 2023
Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff
Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023
Hot topics in renal cell carcinoma and rare tumors
Key data and hot topics in prostate cancer at ASCO GU 2023
Hot Topics in Bladder Cancer at ASCO GU 2023
Approaches to NSCLC With or Without Targetable Mutations
CAR-T in solid tumors: advances and challenges in targeting CLDN18.2, HER2 and STEAP 1
ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa
Breast Cancer Sessions: Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons
Updates in cervical cancer
Resistance to immune checkpoint inhibitors in NSCLC
Impact of race on breast cancer outcomes
Immunotherapy updates in GI cancer
Updates from ESMO Asia 2022
Updates in EGFR-mutant NSCLC
UKONS 2022: cancer care in the digital age
Updates in immunotherapy from SITC 2022
Advances in radiotherapy from ASTRO 2022
Immunotherapy Updates in Head & Neck Cancer
Evolving role of ctDNA in breast cancer
Updates in Immuno-Oncology from ITOC 2022
ESMO 2022: Updates in Sarcoma
GI Cancer Sessions: ESMO Highlights with Geoffrey Ku and Sam Klempner
Breast Cancer Sessions: Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja
ESMO 2022: Updates in Colorectal Cancer
ESMO 2022: Updates in Breast Cancer
ESMO 2022 Daily Round-Ups: Day 4
ESMO 2022 Daily Round-Ups: Day 3
ESMO 2022 Daily Round-Ups: Day 2
The Lung Cancer Sessions: Updates from WCLC 2022
TILs, Cancer Vaccines & the Future of Cellular Therapies in Melanoma with Allison Betof Warner
Updates in lung cancer from WCLC 2022
Updates in checkpoint inhibitors for kidney cancer
iwCART Sessions: CAR-T clinical advances in breast and ovarian cancer
Clinical Applications of ctDNA in Oncology
iwCART Sessions: CAR-T clinical advances in lung cancer
ASCO 2022: Updates in Gastrointestinal Cancer
ASCO 2022: Updates in Genitourinary Cancer
ASCO 2022: Updates in Breast Cancer
ASCO 2022: Updates in Lung Cancer
iwCAR-T Sessions: emerging CARs & challenges in solid tumors
ASCO 2022 Daily Round-Ups: Day 3
ASCO 2022 Daily Round-Ups: Day 2
ASCO 2022 Daily Round-Ups - Day 1
Updates in radiation oncology from ESTRO 2022
Breast Cancer Sessions: Treatment de-escalation in TNBC
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355
Updates in GI cancers from AACR 2022
Expanding use of artificial intelligence (AI) in oncology
The evolving role of nurses amidst global pandemic: perspectives, and highlights from cancer nursing leaders
The GU Cancer Sessions: Prostate & kidney cancer highlights from ASCO GU 2022
Lung Cancer Screening: Current state and future directions
Novel treatment approaches in HR+/HER2- breast cancer
New treatment approaches for advanced or metastatic urothelial carcinoma
The Breast Cancer Sessions: Highlights from SABCS 2021
The GI Cancer Sessions: Highlights from ASCO GI 2022
Prostate Cancer Highlights from ASCO GU 2022
Updates on HER2-positive breast cancer
BTOG 2022: Highlights in lung cancer
The multidisciplinary use of ctDNA in gastrointestinal cancers
SITC 2021: Updates on the use of cellular therapy in solid tumors
Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky
The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC
ISLB 2021: Current standards and future directions for liquid biopsy
Prostate Cancer Highlights from ESMO 2021 from Robert Jones
The GU Cancer Sessions: Bladder Highlights from ESMO 2021
The Lung Cancer Sessions: Highlights from ASCO 2021
The GI Cancer Sessions: Highlights from ASCO 2021
The Skin Cancer Sessions: Highlights from ASCO 2021
Key clinical trial data in urothelial carcinoma at ASCO 2021
Prostate Cancer Highlights from ASCO 2021 with Pedro Barata
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO 2021
The Breast Cancer Sessions: Highlights from ASCO 2021
ASCO 2021: Immunotherapy updates in lung cancer
EAU 2021: updates in testicular cancer
Highlights from ESMO WCGIC 2021: VALENTINO, KEYNOTE-811 & BEACON-CRC
What's new? Treating breast cancer with brain metastases
Global breast cancer care
Latest developments in immunotherapy for patients with melanoma
ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer
ESMO Breast 2021: updates on immunotherapy
The Lung Cancer Sessions: Highlights from BTOG 2021
Sequencing HER2-targeting therapies in the metastatic breast cancer space
The GU Sessions: Prostate Cancer Highlights from ASCO GU 2021
Latest news in GU: CAR-T in RCC, updates from IMvigor130, & liquid biopsies in prostate cancer
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO GU 2021
BTOG 2021: KRAS targeting and oncogenically-driven lung cancer
The Breast Cancer Sessions: a focus on the St. Gallen Consensus
Predictive and prognostic biomarkers in breast cancer
The Lung Cancer Sessions: highlights from IASLC WCLC
The GI Cancer Sessions: Highlights from ASCO GI 2021
The Breast Cancer Sessions: Highlights from SABCS 2020
Highlights from SABCS 2020: immunotherapy, novel agents and trial updates
Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT
Updates in non-small cell lung cancer from ESMO
Highlights from EADO 2020: novel therapies, neoadjuvant approaches & COVID-19
The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend
The ONS/EONS Congress Roundtable Discussion with VJOncology and OncoAlert
Prioritizing patients for breast cancer surgery during COVID-19
Genotyping in lung cancer and multi-cancer detection
Molecular testing for lung cancer in the UK
Living with and beyond cancer: a patient’s quality of life is just as important as survival
Advancing immunotherapy for solid tumors
Updates in breast cancer: recent clinical trials, immunotherapy, challenges & future treatment outlook
Hot topics in oncology: precision medicine, biomarkers & immunotherapy
Bladder cancer: advances in the spotlight and what these mean for therapy